Description
RADIOPHARMACEUTICAL
First action · last action
2022-10-01 · 2023-10-11
Transactions
2
First transaction's obligation
$253,894
Base + all options value (sum of deltas)
$105,612
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA24817D0065
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-10-01+$253,894= $253,894
- Mod P000012023-10-11-$148,281= $105,612
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-10-01 | +$253,894 | $253,894 | RADIOPHARMACEUTICAL |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-10-11 | −$148,281 | $105,612 | RADIOPHARMACEUTICAL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 3650 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24820F0103 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $86,048 | FY2020 |
| 36C24819N1050 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $78,932 | FY2019 |
| VA24817C0163 | MEDI-PHYSICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $134,724 | FY2017 |
| VA24817F2026 | ASTELLAS PHARMA US, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $243,162 | FY2017 |
| VA24816F2532 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $2,849 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24823N0035_3600_VA24817D0065_3600 · retrieved 2026-09-26.